MedTrace Logo

A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test

NCT03620110 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2209

Last updated 2020-01-14

No results posted yet for this study

Summary

The purpose of this study is to collect whole blood samples from women with viable pregnancies of at least 10 weeks gestation (at any risk for fetal chromosomal anomaly) for future testing with an investigational noninvasive prenatal test(s) (NIPTs), and to establish clinical truth compared to a clinical reference standard.

Conditions

  • Pregnancy

Sponsors & Collaborators

  • Agility Clinical, Inc.

    collaborator INDUSTRY

  • Illumina, Inc.

    lead INDUSTRY

Principal Investigators

  • Ronald Wapner, MD · Columbia University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-21
Primary Completion
2019-12-30
Completion
2019-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03620110 on ClinicalTrials.gov